SOPHiA AI Unlocks the Power of Exome Sequencing for Clinical Diagnostics

Sophia Genetics, announces the release of its Whole Exome Solution (WES) and Clinical Exome Solution (CES). Accessible through Sophia DDM®, the company’s analytical platform for clinical diagnostic, these solutions are powered by new knowledge-driven DNA sample preparation kits, which allow clinicians to fully leverage the power of SOPHiA Artificial Intelligence (AI) to get access to broader, deeper and more meaningful clinical insights.

Please to read the entire article.